PAREXEL Introduces New Dedicated Division to Help Emerging Biotech Companies Reach their Goals
Published on:
Applied Clinical Trials
PAREXEL International Corporation, an innovator of global biopharmaceutical services, introduced a new, dedicated division to help emerging biotech companies in reaching their drug development and commercialization goals quickly and cost-effectively. PAREXEL utilizes different strategies and services such as consulting, patient recruitment, trial execution, and Real World Evidence programs in order to help companies reach their objectives.
